Open AccessStopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect
Author(s) -
Felix Stader,
Saye Khoo,
Marcel Stoeckle,
David Back,
Hans H. Hirsch,
Manuel Battegay,
Catia Marzolini
Publication year - 2020
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkaa253
Subject(s) - lopinavir , ritonavir , lopinavir/ritonavir , covid-19 , medicine , virology , drug , coronavirus , infectious disease (medical specialty) , pharmacology , viral load , human immunodeficiency virus (hiv) , disease , antiretroviral therapy , outbreak
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom